For citations:

Fedorov ES, Salugina SO, Zakharova EY, Kamenets EA, Gerasimenko AN. Low-penetrance R92Q (p.Arg121Gln) mutation in the TNFRSF1A gene: the significance and variants of phenotypes. Successful experience with the interleukin-1 inhibitor canakinumab in a female patient, who is a carrier of R92Q mutation with a severe TRAPS phenotype. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2020;14(3):102-110. https://doi.org/10.14412/1996-7012-2020-3-102-110